Carly Helfand on Muck Rack

Carly Helfand

Verified
Washington, D.C.
Senior Editor, FiercePharma and FiercePharmaMarketing — FiercePharma

Reporter/editor for @FiercePharma and FiercePharmaMarketing; Chicago native; intent traveler; hockey fan; Irish fiddler; comma police.

Search Tweets

Twitter Feed

@CarlyHFierce — 2,413 followers, 4,250 tweets

Amgen kicks off 2018 with double the good news for slow-growing Kyprolis:  http://bit.ly/2EW2lEW  $AMGN #pharma
Look out, Allergan: Doctor surveys show the 'Botox competitive threat is real':  http://bit.ly/2DsQHUZ  $AGN #pharma
Boehringer's Gilotrif widens its reach in crowded EGFR lung cancer field:  http://bit.ly/2rcSf0o  #pharma
NICE shoots down Pfizer's Xalkori in ROS1-positive patients, inviting a CDF proposal instead:  http://bit.ly/2DrbDfe  $PFE #pharma
GlaxoSmithKline eyes $1.7B bid for respiratory partner Vectura: report  http://bit.ly/2DE8ndT  $GSK #pharma
Show More